NCT04743661 2026-02-05131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor ConsortiumPhase 2 Active not recruiting62 enrolled
NCT03332667 2025-04-16MIBG With Dinutuximab +/- VorinostatNew Approaches to Neuroblastoma Therapy ConsortiumPhase 1 Completed45 enrolled 16 charts